Comparison of Two Contraceptive Pills Containing Drospirenone and 20 μg or 30 μg Ethinyl Estradiol for Polycystic Ovary Syndrome

    Sudhindra Mohan Bhattacharya, Ayan Jha, Lipika DasMukhopadhyay
    Studysummary Among women with polycystic ovary syndrome, this study found that oral contraceptives containing 20 μg ethinyl estradiol had similar effects on androgen levels as those containing 30 μg.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline The Journal of Clinical Endocrinology and Metabolism · 2006
    2. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004
    3. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS) Human Reproduction · 2003

    Related research 1

    1. Comparison of Two Contraceptive Pills Containing Drospirenone and 20 μg or 30 μg Ethinyl Estradiol for Polycystic Ovary Syndrome International Journal of Gynecology & Obstetrics · 2015